China’s Xpeng expects to start delivering ’flying’ cars in 2027

Xpeng said it expects large-scale production of its flying cars next year and humanoid robots in Q4 2026, while planning robotaxi tests in Guangzhou this year. The company has already received more than 7,000 flying-car orders and said robotaxis could reach hundreds to thousands of units over the next 12 to 18 months. Management also signaled meaningful international growth, with overseas revenue projected to rise from about 15% last year to more than 50% within five to 10 years.

Analysis

XPEV is trying to re-rate from a cyclical EV assembler into a platform company with optionality across mobility, robotics, and software. The market usually gives zero value to far-dated adjacency bets, but the important second-order effect is capital allocation: every yuan diverted into flying cars, robotaxis, and humanoids increases execution dispersion and delays the proof point investors actually pay for today — automotive margin durability. That creates a near-term tension: headline innovation can support multiple expansion, yet it also raises the probability of a valuation reset if commercialization slips.

The bigger strategic signal is the Volkswagen relationship. If Xpeng becomes the preferred China/OEM development partner, the real upside is not unit volume but fee-based engineering leverage and a lower customer acquisition cost for future partnerships in Europe and possibly emerging markets. The flip side is bargaining power: once a large incumbent validates Xpeng’s platform, rivals will push for similar access, compressing economics unless Xpeng can keep its stack differentiated. That makes this less a pure EV story and more a race to establish standard-setting power before the ecosystem fragments.

The robotics and flying-car angles should be treated as call options with long-dated catalysts, not core earnings drivers. The first meaningful inflection is regulatory and operational credibility over the next 6-18 months; until then, the stock can trade on narrative momentum, but that momentum is fragile because any safety incident, certification delay, or weak unit economics will hit all three optionality pillars at once. The contrarian view is that the market may be underestimating how much overseas mix can stabilize revenue, but overestimating how quickly non-auto businesses can be monetized.

Key Decisions for Investors

• Long XPEV vs short a global OEM basket over 3-6 months if you want exposure to optionality re-rating; stop-loss on any regulatory setback or delayed production commentary.
• Sell out-of-the-money XPEV calls into any post-news strength; this is a classic narrative-driven spike where implied vol can overstate near-term fundamental acceleration.
• If we want cleaner exposure to the partner-value thesis, pair long XPEV / short a China EV pure-play with weaker strategic leverage; the spread should widen if Volkswagen cooperation deepens.
• Do not chase the humanoid/flying-car angle outright for the next 12 months; treat it as a long-dated call option and only add on pullbacks after certification or pilot milestones.
• For a tactical trade, buy XPEV on a 2-4 week dip after enthusiasm fades, targeting the next partnership or overseas-revenue update; risk/reward improves when the market stops paying for the headline and starts pricing execution.